What New York Medicaid actually covers for Wegovy, Zepbound, Ozempic and Mounjaro. Most state Medicaid programs still exclude weight-loss-indication GLP-1, but the diabetes path is covered nearly everywhere with prior authorization (your doctor asks the plan to approve it first). Here is the current 2026 reality for New York.
Coverage summary
| Indication | Coverage |
|---|---|
| Wegovy (weight loss) | No |
| Zepbound (weight loss) | No |
| Ozempic / Mounjaro (type 2 diabetes) | Yes |
| Compounded semaglutide / tirzepatide | No |
Prior-authorization criteria
These rules come from the state preferred drug list (PDL), the list of drugs New York Medicaid has agreed to pay for.
| Criterion | Value |
|---|---|
| PA burden | High |
| BMI threshold (weight-loss path) | Not applicable (weight-loss path not covered) |
| Comorbidity required | No |
| Last PDL update reviewed | 2026-07-16 |
What this means in practice
New York Medicaid (NYRx) does not cover GLP-1s for weight loss alone. State law does not let Medicaid pay for a drug whose only job is weight loss. Two narrow exceptions sit on the drug list revised July 16, 2026. Wegovy if you have diagnosed heart disease. Zepbound if you have diagnosed sleep apnea. Both need a BMI of 40, and New York allows only two rounds of treatment in your lifetime. Obesity on its own does not qualify at any BMI. If you were denied, an appeal is the realistic next move.
Managed-care organizations in New York (16 contracted)
New York Medicaid contracts with the following managed-care organizations (MCOs), the private health plans the state pays to run day-to-day Medicaid coverage. MCO formularies must meet or exceed the state PDL but can layer in additional criteria. Verify your assigned MCO's most recent PA policy before submitting.
- Healthfirst
- Fidelis Care (Centene)
- EmblemHealth
- MetroPlus Health Plan
- MVP Health Care
- Affinity Health Plan
Cash-pay alternatives if Medicaid does not cover you
New York will not pay for a GLP-1 for weight alone, so the realistic routes are a documented heart-disease or sleep-apnea diagnosis, the type 2 diabetes path, or paying cash. Compounded semaglutide starts around $149 a month.
If you end up paying cash, the GLP-1 cost guide breaks down what every legitimate path actually costs at maintenance dose, from the $149-a-month compounded floor to branded manufacturer-direct pricing. For ranked cash-pay options, see programs ranked by price and programs under $150 a month. Manufacturer savings cards and patient-assistance programs are not routes here: federal law bars the cards for anyone on Medicaid, and the free-drug programs require being uninsured.
Two routes sit outside Medicaid entirely. If a supply gap rather than cost is blocking your refill, the GLP-1 shortage tracker shows which formulations the FDA lists as in shortage now. And if you are 65 or older and also have Medicare, the senior GLP-1 hub lays out the Medicare coverage paths for dual-eligible patients.
For the full cash-pay picture specific to New York, including which programs serve New York residents and the New York Medicaid cost comparison, see the cheapest GLP-1 in New York guide.
Take it to your prescriber: PA letter library
If you qualify under one of the covered indications above, the prior-authorization route is the cheapest path. We maintain a PA letter library with templates for Aetna, Cigna, UnitedHealthcare, Anthem BCBS, Kaiser, Humana, Tricare, FEHB and Medicare Advantage, cross-indexed against six qualifying clinical pictures. Each template cites the plan's policy document, the qualifying ICD-10 codes and the registration-trial evidence.
If you have type 2 diabetes plus chronic kidney disease and established cardiovascular disease, the triple-indication evidence stack (FLOW + SELECT + SUSTAIN-6) is the strongest PA path in any state.
If your PA is denied, the appeal letter library has denial-specific templates. For the commercial and Medicare coverage paths, see the GLP-1 insurance guide.
New York Medicaid GLP-1 FAQ
Does New York Medicaid cover Wegovy for weight loss?
Does New York Medicaid cover Zepbound for weight loss?
Does New York Medicaid cover Ozempic or Mounjaro for diabetes?
What if New York Medicaid does not cover my GLP-1?
Other state Medicaid pages
See the full 51-state coverage table for the side-by-side view across every US state.
How we built this page
Compiled from each state Medicaid's published preferred drug list, PA criteria and PDL committee minutes. State Medicaid programs are not federally required to cover obesity drugs; the diabetes indication is covered nearly everywhere with PA. State-level data is point-in-time and shifts each PDL cycle. Always verify with your state Medicaid plan before relying on this page.
Last updated: 2026-07-20. We check each state Medicaid PDL and PA criteria quarterly. If you have recently had a different experience with New York Medicaid, email hello@glpchart.com with the details and we will check it.
